Features of coronary pathology and its relationship with myocardial fibrosis markers in patients with resistant hypertension

QR Code

Features of coronary pathology and its relationship with myocardial fibrosis markers in patients with resistant hypertension

Aim. To evaluate the severity of coronary atherosclerosis and its association with biochemical markers of fibrosis in patients with coronary artery disease (CAD) and resistant hypertension (RHT).Material and methods. The study included 39 patients with CAD and RHT. All patients underwent 24-hour blo...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. A. Lichikaki, V. F. Mordovin, A. Yu. Falkovskaya, I. V. Zyubanova, M. A. Manukyan, E. I. Solonskaya, A. A. Vtorushina, S. A. Khunkhinova, I. A. Skomkina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2023-07-01
Series:	Российский кардиологический журнал
Subjects:	obstructive coronary atherosclerosis myocardial fibrosis resistant hypertension blood pressure lipocalin matrix metalloproteinases
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5394
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Regression of left ventricular hypertrophy in patients with resistant hypertension after renal denervation: the role of hemodynamic and antifibrotic effects
by: E. I. Solonskaya, et al.
Published: (2024-06-01)

Production of factors involved into fibrosis regulation by various types of human macrophages
by: A. A. Maksimova, et al.
Published: (2020-08-01)

EXTRACELLULAR MATRIX CONDITION IN CASE OF HCVASSOCIATED LIVER FIBROSIS
by: I. S. Gorelova, et al.
Published: (2017-01-01)

Lipocalin associated with neutrophil gelatinase, matrix metalloproteinases 2 and 9 in the pathogenesis of acute kidney injury in thermal skin burns
by: A. A. Konovalova
Published: (2024-12-01)

Correlation between markers of fibrosis and myocardial remodeling in patients with various course of hypertrophic cardiomyopathy
by: F. M. Bogatyreva, et al.
Published: (2022-03-01)

Role of Gene Polymorphisms of Matrix Metalloproteinases-2, -3 and -13 in the Development of Coronary Artery Atherosclerosis in Patients with Primary Polyosteoarthrosis
by: O. O. Portyannikova, et al.
Published: (2020-03-01)

Age-associated level of myocardial fibrosis markers and chemokines in patients with acute coronary syndrome
by: O. A. Osipova, et al.
Published: (2021-09-01)

Fibrogenic and fibrolytic potential of differently activated human macrophages
by: A. A. Maksimova, et al.
Published: (2023-06-01)

Complex studies on gene polymorphisms of MMP2, MMP3, MMP9 matrix metalloproteinases and TIMP1, TIMP2 tissue inhibitors of metalloproteinases in the patients with primary open-angle glaucoma
by: A. V. Shevchenko, et al.
Published: (2023-04-01)

Parameters of the mmp / timp system in assessing the clinical course of pulmonary tuberculoma
by: D. S. Esmedlyaeva, et al.
Published: (2024-04-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
by: Ye. V. Klisho, et al.
Published: (2011-02-01)

Nkx2‐5 Is Expressed in Atherosclerotic Plaques and Attenuates Development of Atherosclerosis in Apolipoprotein E–Deficient Mice
by: Meng Du, et al.
Published: (2016-12-01)

Levels of metalloproteinases and adipose tissue hormones in men with coronary atherosclerosis
by: Ya. V. Polonskaya, et al.
Published: (2024-01-01)

Local proteolytic system indicators as suspective factors of keratolysis development after urgent keratoplasty
by: E. V. Chentsova, et al.
Published: (2024-07-01)

FEATURES OF CYTOKINE PROFILE IN PATIENTS WITH ATHEROSCLEROSIS
by: E. P. Turmova, et al.
Published: (2014-08-01)

Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy
by: V. P. Mikhin, et al.
Published: (2022-11-01)

Features of the level of matrix metalloproteinase-2, -3, -9 and tissue inhibitors of metalloproteinases-1, -2, -3, -4 in the aqueous humor of patients with primary open-angle glaucoma
by: V. V. Chernykh, et al.
Published: (2022-01-01)

MMP14 as a central mediator of TGF-β1−induced extracellular matrix remodeling in graves’ orbitopathy
by: Xing Wang, et al.
Published: (2025-07-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Gaylussacin, a stilbene glycoside, inhibits chronic obstructive pulmonary disease in mice
by: Hye-Young Min, et al.
Published: (2025-09-01)

Beta-adrenergic reactivity of erythrocyte membranes in various phenotypes of uncontrolled hypertension
by: M. A. Manukyan, et al.
Published: (2024-06-01)

Clinical and prognostic significance of matrix metalloproteinases in patients with myocardial infarction
by: T. B. Pecherina, et al.
Published: (2019-06-01)

Pathogenetic mechanisms of ascending aortic aneurysm of varied aetiology
by: O. B. Irtyuga, et al.
Published: (2013-02-01)

Connective tissue and the problems of its pathological conditions
by: V. A. Shkurupy, et al.
Published: (2018-01-01)

Risk factors for impaired motor development in late preterm infants: A prospective cohort study
by: E. I. Kleshchenko, et al.
Published: (2025-02-01)

Inflammatory activity and markers of extracellular matrix destruction in pulmonary tuberculoma
by: D. S. Esmedlyaeva, et al.
Published: (2020-07-01)

Features of brain magnetic resonance imaging (MRI) changes under the influence of renal denervation in patients with resistant hypertension
by: V. A. Lichikaki, et al.
Published: (2023-08-01)

Matrix metalloproteinases and their inhibitors
by: O. S. Grigorkevich, et al.
Published: (2019-02-01)

Polymorphic locus RS11568818 of the MMP7 gene is associated with the development of essеntial hypertension in women
by: M. I. Moskalenko, et al.
Published: (2018-11-01)

The possibilities of using the inhibitors of matrix metalloproteinases for keratoplasty
by: K. V. Sirotkina, et al.
Published: (2023-09-01)

Metalloproteinases as biochemical markers of pregnancy pathology
by: K. N. Grigorieva, et al.
Published: (2022-03-01)

Nocturnal hypoxemia, cardiac remodeling, and blood concentrations of fibrosis biomarkers in patients with atrial fibrillation and obstructive sleep apnea
by: V. A. Berdysheva, et al.
Published: (2025-01-01)

On clean hyperrings
by: Taybeh Amouzegar, et al.
Published: (2015-06-01)

Matrix metalloproteinases in the oral fluid as a characteristic of inflammatory-destructive process in periodontal tissues
by: A.V. Samoilenko, et al.
Published: (2022-09-01)

Matrix metalloproteinase 9, superoxide dismutase and lipid peroxidation in preterm newborns with perinatal hypoxia
by: Yu. V. Korenovsky, et al.
Published: (2011-04-01)

The activity of matrix metalloproteinases and the concentration of their tissue inhibitors in the blood serum of patients with type 2 diabetes mellitus, depending on the stage of compensation of the disease
by: A. V. Zubova, et al.
Published: (2021-12-01)

USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS IN TREATMENT OF RECURRENT PRE-MENSTRUAL ENDOMETRIAL HYPERPLASIA
by: Yu. E. Dobrokhotova, et al.
Published: (2016-09-01)

Dynamics of Matrix Metalloproteinases in Local Cold Injury
by: M. I. Mikhailichenko, et al.
Published: (2019-11-01)

Ion Exchange Disorders
by: P. F. Litvitsky
Published: (2015-08-01)